Curaegis Technologies (OTCMKTS:CRGS) and Adient (NYSE:ADNT) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, analyst recommendations, profitability, institutional ownership and valuation.

Valuation and Earnings

This table compares Curaegis Technologies and Adient’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Curaegis Technologies $40,000.00 253.27 -$5.42 million N/A N/A
Adient $17.44 billion 0.07 -$1.69 billion $5.62 2.48

Curaegis Technologies has higher earnings, but lower revenue than Adient.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Curaegis Technologies and Adient, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Curaegis Technologies 0 0 0 0 N/A
Adient 5 8 2 0 1.80

Adient has a consensus target price of $31.00, indicating a potential upside of 122.22%. Given Adient’s higher possible upside, analysts clearly believe Adient is more favorable than Curaegis Technologies.


Adient pays an annual dividend of $1.10 per share and has a dividend yield of 7.9%. Curaegis Technologies does not pay a dividend. Adient pays out 19.6% of its earnings in the form of a dividend.

Volatility & Risk

Curaegis Technologies has a beta of -0.56, indicating that its share price is 156% less volatile than the S&P 500. Comparatively, Adient has a beta of 2.17, indicating that its share price is 117% more volatile than the S&P 500.


This table compares Curaegis Technologies and Adient’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Curaegis Technologies -16,002.38% N/A -408.57%
Adient -8.54% 13.15% 3.94%

Insider & Institutional Ownership

0.1% of Curaegis Technologies shares are held by institutional investors. 40.0% of Curaegis Technologies shares are held by company insiders. Comparatively, 0.5% of Adient shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.


Adient beats Curaegis Technologies on 8 of the 13 factors compared between the two stocks.

Curaegis Technologies Company Profile

CurAegis Technologies, Inc. develops and markets advanced technologies in the areas of power, safety, and wellness. The company operates through two segments, CURA and Aegis. It focuses on the commercialization of various technologies, including myCadian watch, a wearable device, which is used to predict and detect the degradation of alertness in a user, and reveal sleep and fatigue problems; Z-Coach, an e-learning tool that offers sleep training and education solutions to correct sleep issues and enhance overall wellness; and hydraulic pumps for off road diesel engines. The company was formerly known as Torvec, Inc. and changed its name to CurAegis Technologies, Inc. in June 2016. CurAegis Technologies, Inc. was founded in 1996 and is headquartered in Rochester, New York.

Adient Company Profile

Adient plc designs, manufactures, and markets a range of seating systems and components for passenger cars, commercial vehicles, and light trucks. It operates through three segments: Seating, Seat Structures and Mechanisms (SS&M), and Interiors. The Seating segment produces seat systems for automotive and other mobility applications, as well as various components of seat systems, including foams, trims, and fabrics. The SS&M segment produces seat structures and mechanisms for inclusion in seat systems that are produced by others. The Interiors segment produces instrument panels, floor consoles, door panels, overhead consoles, cockpit systems, decorative trims, and other products. The company operates in the Americas, Europe, China, and internationally. Adient plc was incorporated in 2016 and is based in Dublin, Ireland.

Receive News & Ratings for Curaegis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaegis Technologies and related companies with's FREE daily email newsletter.